Related Experiment Video
Updated: Jun 13, 2026

Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro
Lesa R Black1, Christopher Aiken
1Department of Microbiology and Immunology, Vanderbilt University School of Medicine, A-5301 Medical Center North, Nashville, TN 37232-2363, USA.
Abstract:
The host restriction factor TRIM5alpha provides intrinsic defense against retroviral infections in mammalian cells. TRIM5alpha blocks infection by targeting the viral capsid after entry but prior to completion of reverse transcription, but whether this interaction directly alters the structure of the viral capsid is unknown. A previous study reported that rhesus macaque TRIM5alpha protein stably associates with cylindrical complexes formed by assembly of recombinant HIV-1 CA-NC protein in vitro and that restriction leads to accelerated HIV-1 uncoating in target cells. To gain further insight into the mechanism of TRIM5alpha-dependent restriction, we examined the structural effects of TRIM5 proteins on preassembled CA-NC complexes by electron microscopy. Incubation of assembled complexes with lysate of cells expressing the restrictive rhesus TRIM5alpha protein resulted in marked disruption of the normal cylindrical structure of the complexes. In contrast, incubation with lysate of control cells or cells expressing comparable levels of the nonrestrictive human TRIM5alpha protein had little effect on the complexes. Incubation with lysate of cells expressing the TRIMCyp restriction factor also disrupted the cylinders. The effect of TRIMCyp was prevented by the addition of cyclosporine, which inhibits binding of TRIMCyp to the HIV-1 capsid. Thus, disruption of CA-NC cylinders by TRIM5alpha and TRIMCyp was correlated with the specificity of restriction. Collectively, these results suggest that TRIM5alpha-dependent restriction of HIV-1 infection results from structural perturbation of the viral capsid leading to aberrant HIV-1 uncoating in target cells.
Insights
The host restriction factor TRIM5alpha disrupts the structure of HIV-1 capsids, leading to premature uncoating and blocking viral infection in mammalian cells.
Area of Science:
- Immunology
- Virology
- Structural Biology
Background:
- The host restriction factor TRIM5alpha is crucial for intrinsic defense against retroviral infections in mammalian cells.
- TRIM5alpha targets the viral capsid post-entry but before reverse transcription, yet its direct structural impact on the capsid is unknown.
- Previous work showed rhesus macaque TRIM5alpha associates with HIV-1 capsid protein complexes and accelerates viral uncoating.
Purpose of the Study:
- To investigate the structural effects of TRIM5 proteins on preassembled HIV-1 capsid complexes.
- To elucidate the mechanism of TRIM5alpha-dependent retroviral restriction.
Main Methods:
- Electron microscopy was used to examine structural changes in assembled HIV-1 capsid protein (CA-NC) complexes.
- Complexes were incubated with lysates from cells expressing rhesus TRIM5alpha, human TRIM5alpha, or TRIMCyp.
- The effect of cyclosporine on TRIMCyp-mediated disruption was assessed.
Main Results:
- Lysate from cells expressing restrictive rhesus TRIM5alpha markedly disrupted the cylindrical structure of CA-NC complexes.
- Non-restrictive human TRIM5alpha had minimal effect, while TRIMCyp also caused disruption.
- TRIMCyp's effect was blocked by cyclosporine, confirming its capsid-binding-dependent mechanism.
Conclusions:
- Structural perturbation of the HIV-1 capsid by TRIM5alpha correlates with its restriction activity.
- TRIM5alpha-mediated restriction likely occurs through inducing aberrant viral uncoating.
- These findings provide mechanistic insight into TRIM5alpha's role in innate antiviral defense.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Inhibitors of Viral Protein Synthesis
Viral Structure
Inhibitors Of Virion Release
Size and Structure of Viral Genomes

